Skip to main content
Michael Gibson, MD, Oncology, Nashville, TN

Michael Gibson MD

Gastrointestinal Cancer, Head & Neck Cancer


Associate Professor of Medical Oncology, Case Western University Seidman Cancer Center

Join to View Full Profile
  • 3601 The Vanderbilt ClinicNashville, TN 37232

  • Phone+1 615-322-3000

  • Fax+1 615-936-0605

Dr. Gibson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Michael Gibson is an oncologist in Nashville, TN and is affiliated with multiple hospitals in the area, including University Hospitals Cleveland Medical Center and Vanderbilt University Medical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 20 years. He specializes in gastrointestinal cancer, hiv/aids related, head & neck cancer, and hematologic oncology and is experienced in lung cancer, head and neck oncology, thyroid neoplasms, gastrointestinal oncology, and general medical oncology.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2000 - 2004
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1999
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1996

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2017 - 2025
  • AL State Medical License
    AL State Medical License 2020 - 2020
  • OH State Medical License
    OH State Medical License 2013 - 2019
  • PA State Medical License
    PA State Medical License 2007 - 2014
  • MD State Medical License
    MD State Medical License 1999 - 2008
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Michael Gibson Votes with FDA Panel to Limit Immunotherapy Indication
    Michael Gibson Votes with FDA Panel to Limit Immunotherapy IndicationOctober 30th, 2024
  • University Hospitals Seidman Cancer Center Enrolls First Patient in New National Head and Neck Cancer Study
    University Hospitals Seidman Cancer Center Enrolls First Patient in New National Head and Neck Cancer StudyFebruary 23rd, 2017
  • Dr. Michael Gibson&Carly O'Brien–New Treatment Helps Those Suffering W/ Head & Neck Cancer 12.28.16
    Dr. Michael Gibson&Carly O'Brien–New Treatment Helps Those Suffering W/ Head & Neck Cancer 12.28.16December 28th, 2016
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: